353 related articles for article (PubMed ID: 37256537)
1. Diagnostic and Therapeutic Updates in Leptomeningeal Disease.
Roy-O'Reilly MA; Lanman T; Ruiz A; Rogawski D; Stocksdale B; Nagpal S
Curr Oncol Rep; 2023 Aug; 25(8):937-950. PubMed ID: 37256537
[TBL] [Abstract][Full Text] [Related]
2. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
4. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid.
White MD; Klein RH; Shaw B; Kim A; Subramanian M; Mora JL; Giobbie-Hurder A; Nagabhushan D; Jain A; Singh M; Kuter BM; Nayyar N; Bertalan MS; Stocking JH; Markson SC; Lastrapes M; Alvarez-Breckenridge C; Cahill DP; Gydush G; Rhoades J; Rotem D; Adalsteinsson VA; Mahar M; Kaplan A; Oh K; Sullivan RJ; Gerstner E; Carter SL; Brastianos PK
JAMA Netw Open; 2021 Aug; 4(8):e2120040. PubMed ID: 34369989
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal disease in glioblastoma: endgame or opportunity?
Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Diagnosis and Treatment of Leptomeningeal Disease.
Sharma A; Low JT; Kumthekar P
Curr Neurol Neurosci Rep; 2022 Jul; 22(7):413-425. PubMed ID: 35588045
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
[TBL] [Abstract][Full Text] [Related]
14. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.
Thomas KH; Ramirez RA
Ochsner J; 2017; 17(4):362-378. PubMed ID: 29230121
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Gajjar A; Boyett JM; Walter AW; Thompson SJ; Merchant TE; Jenkins JJ; Langston JW; Liu A; Kun LE; Heideman RL
J Clin Oncol; 1999 Oct; 17(10):3234-7. PubMed ID: 10506624
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD).
Ferguson SD; Fomchenko EI; Guerrieri RA; Glitza Oliva IC
Front Oncol; 2021; 11():800053. PubMed ID: 35096602
[TBL] [Abstract][Full Text] [Related]
18. Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Mills MN; King W; Soyano A; Pina Y; Czerniecki BJ; Forsyth PA; Soliman H; Han HS; Ahmed KA
J Neurooncol; 2022 Apr; 157(2):249-269. PubMed ID: 35244835
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
20. Latest clinical research in leptomeningeal disease (LMD)-a narrative review.
Chan AW; Wong HCY; Taphoorn M; Dirven L; Le Rhun E; Soliman H; Oldenburger E; Raman S; Vassiliou V; Bonomo P; Koller M; Marta GN; Rembielak A; Lee SF; Chow E; Simone CB
Ann Palliat Med; 2023 Nov; 12(6):1215-1231. PubMed ID: 37953219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
